Tirzepatide Peptide | 99% High Purity | GLP-1 GIP Peptide Raw Material | Lyophilized Powder Vials | 10mg 15mg 20mg 60mg
2103 Inquiries
2023788-19-2
Pharmaceutical Grade
99%
HongKong
HUATI
10via/kit
2026-08-30
Tirzepatide,Retatrutide,NAD+,Samaglutide,GHK-CU,cagrilintide
-
Product Details
-
Seller Information
-
Inquiry History
-
DescriptionECHEMI Editorial Reference
Tirzepatide (LY3298176) was developed as a dual agonist to both GLP-1 and gastric inhibitory polypeptide (GIP) receptors (Frias et al., 2018). Similar to GLP-1, GIP is an incretin hormone that functions to induce insulin secretion.
Basic Info-
Product Name:
Tirzepatide
Other Name:LY3298176;
CAS No.:2023788-19-2
Molecular Formula:C225H348N48O68
Molecular Weight:4813
EC Number:200-001-8
Categories:
Characteristics-
Appearance:
White to off-white
Research-
Class:
Dual agonist — GIPR, GLP-1R
Status:FDA-approved (Mounjaro / Zepbound)
Mechanism:Dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. A 39-amino-acid modified peptide with a C20 fatty diacid moiety that enables albumin binding for extended half-life (~5 days). Selectively activates both GIPR and GLP-1R signaling pathways.
EC50 (Human GLP1R):0.934 nM
EC50 (Human GIPR):0.0224 nM
Source:Frias JP, et al. N Engl J Med. 2021;385(6):503-515.DOI
Clinical Development:NCT03954834; NCT03987919; NCT03882970; NCT03730662; NCT04039503
FDA:Mounjaro, Zepbound (approved 2022-05-13)
References-
ChEMBL:DrugBank:KEGG DRUG:PubChem:Disclaimer:
Tirzepatide is approved as a prescription medicine (Mounjaro, Zepbound) in certain jurisdictions. This listing is for industrial and laboratory research use only. Research-chemical listings on B2B marketplaces are not interchangeable with approved medicines. Confirm CAS, specification, and regulatory pathway with the seller. It is not medical advice, a clinical recommendation, or an approved therapy description.
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
Tirzepatide,Retatrutide,NAD+,Samaglutide,GHK-CU,cagrilintide
-
Location:
1502A1, Building 4, Xinyuanxin Center, No. 3 Huaxin Road, Dongfeng Street, Licheng District, Jinan City, Shandong Province
-
Payment Terms:
TT against B/L draft before shipment,100% TT in advance
-
Average lead Time:
1 days
-
Total Annual Revenue:
$10 million-$25 million
-
Total Employees:
51-100
-
Year of Establishment:
2026
Company Certificates-
COA
-
COA
-
COA
-
COA
-
COA
-
COA
-
COA
-
COA
-
COA
-
COA
-
COA
-
COA
-
-
Inquiry History2103 Inquiries
Country Product Purchase Quantity Date Posted
Brazil
Tirzepatide
100 G Oct 28, 2026
Belgium
Tirzepatide
10 MG Oct 28, 2026
United States
tirzepatide
100 MG Oct 28, 2026
United States
Tirzepatide
60 MG Oct 28, 2026
United States
Tirzepatide
10 PCS Oct 28, 2026
United States
tirzepatide
30 MG Oct 27, 2026
United States
Tirzepatide
40 MG Oct 27, 2026
Philippines
Tirzepatide
2 MT Oct 27, 2026
Philippines
Tirzepatide
30 MG Oct 26, 2026
Slovakia
Tirzepatide
1 G Oct 26, 2026
France
Tirzepatide
1 KG Oct 25, 2026
United States
Tirzepatide
2.5 MG Oct 25, 2026
United Kingdom
Tirzepatide
5 MT Oct 25, 2026
United Kingdom
Tirzepatide
6 MT Oct 24, 2026
Peru
tirzepatide
10 MG Oct 21, 2026
Puerto Rico
tirzepatide
40 MG Oct 21, 2026
United States
Tirzepatide
10 MT Oct 21, 2026
South Africa
Tirzepatide
1 MT Oct 20, 2026
United States
Tirzepatide
5 KG Oct 20, 2026
United States
tirzepatide
30 MG Oct 20, 2026 Post an enquiry for this product
More from this Seller
-
-
-
KPV L - valine 99 % White crystalline powder Arshine high quality Betty
Pharmaceutical / 99%
$5/UNIT FOB
-
-
-
-
SLU-PP-322 | Cosmetic Peptides for Advanced Research| 99% Purity | Lyophilized Powder | hign quality Betty
Pharmaceutical / 99%
$5/UNIT FOB
-
-
-
-
Samaglutide SM10 10mg*10vials
Pharmaceutical Grade / 99%
-
-
-
-
DAC CD5 Synthetic Acid Peptide Lyophilized Powder For Lab Research
ep / 99%
$5/G FOB
-
-
-
-
Obesity with the Low Pric99% purity H10 Betty
Pharmaceutical / 99%
$5/UNIT FOB
-
-
-
-
METHENOLONE ENANTHATE 10ml x 100 mg/ml/vial Betty
Pharmaceutical / 99%
$5/UNIT FOB
-





